Review
doi: 10.1007/978-1-59745-210-6_9.
Drug delivery in cancer using liposomes
Affiliations
- PMID: 18369969
- DOI: 10.1007/978-1-59745-210-6_9
Item in Clipboard
Review
Drug delivery in cancer using liposomes
Methods Mol Biol.
2008.
Abstract
There are various types of liposomes used for cancer therapy, but these can all be placed into three distinct categories based on the surface charge of vesicles: neutral, anionic and cationic. This chapter describes the more rigorous and easy methods used for liposome manufacture, with references, to aid the reader in preparing these formulations in-house.
Similar articles
-
Physical mechanisms and methods employed in drug delivery to tumors.Acta Pharm. 2007 Sep;57(3):249-68. doi: 10.2478/v10007-007-0021-9. Acta Pharm. 2007. PMID: 17878107 Review.
-
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.Trends Pharmacol Sci. 2009 Nov;30(11):592-9. doi: 10.1016/j.tips.2009.08.004. Trends Pharmacol Sci. 2009. PMID: 19837467 Review.
-
Nanoparticle technologies for cancer therapy.Handb Exp Pharmacol. 2010;(197):55-86. doi: 10.1007/978-3-642-00477-3_2. Handb Exp Pharmacol. 2010. PMID: 20217526 Review.
-
Liposomal drug delivery systems--clinical applications.Acta Pharm. 2005 Mar;55(1):1-25. Acta Pharm. 2005. PMID: 15907221 Review.
-
Passive and active drug targeting: drug delivery to tumors as an example.Handb Exp Pharmacol. 2010;(197):3-53. doi: 10.1007/978-3-642-00477-3_1. Handb Exp Pharmacol. 2010. PMID: 20217525 Review.
Cited by
-
Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes.Bioengineered. 2022 Jun;13(6):14681-14718. doi: 10.1080/21655979.2022.2100863. Bioengineered. 2022. PMID: 35946342 Free PMC article. Review.
-
Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.Mol Ther. 2015 Jun;23(6):1092-1102. doi: 10.1038/mt.2015.42. Epub 2015 Mar 19. Mol Ther. 2015. PMID: 25868400 Free PMC article.
-
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Nanomedicine (Lond). 2010 Jun;5(4):597-615. doi: 10.2217/nnm.10.35. Nanomedicine (Lond). 2010. PMID: 20528455 Free PMC article. Review.
-
Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation.Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1284-8. doi: 10.1073/pnas.0912811107. Epub 2009 Dec 23. Proc Natl Acad Sci U S A. 2010. PMID: 20080563 Free PMC article.
-
Slp-coated liposomes for drug delivery and biomedical applications: potential and challenges.Int J Nanomedicine. 2019 Feb 20;14:1359-1383. doi: 10.2147/IJN.S189935. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30863066 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
